This gallery showcases some of the great scientific and educational posters that were submitted for presentation at the in-person 2020 CADTH Symposium that was cancelled because of COVID-19.

Additional posters will be added to the gallery until September 30, 2020.

Stay tuned for the announcement of the Best Student Poster that will be awarded by an expert panel in October 2020.

The opinions, assumptions, interpretation, statements, and conclusions expressed in the posters are those of the identified authors and co-authors. As such, they are independent of CADTH and do not necessarily represent or reflect the view of CADTH. No endorsement by CADTH is intended or should be inferred.

E-Poster TitlePresenter(s)Co-AuthorsPoster, Videos and Audio
Early Life Exposure to Antibiotics and the Risk of Mood and Anxiety Disorders in Children and Adolescents: A Population-Based Cohort StudyDr. Mahin Delara, Queen's UniversityPoster
Suboxone Microdosing in a Patient Taking a High Dose of Methadone with QTc Prolongation in and Out-Patient SettingDr. Stephen Lee-Cheong, BC Mental HealthDr. Pooria Ghadiri, McGill UniversityPoster
The Use of Health Care Resource Utilization Costs for Treatment-Resistant Depression as Evidence for Decision-Making in the Canadian Health Care System Eneda Pone, Janssen Inc.
David Zante, Janssen Inc.
Quantifying the Burden of Treatment-Resistant Depression in Ontario: Shedding Light on an Important Mental Health Issue Dr. Roger McIntyre, University Health Network; University of TorontoBrad Millson, IQVIA
Sarah Power, IQVIA
Exploring Reasons of Discrepancies Between Health Canada Notice of Compliance (NOC) and INESSS’s Recommendations Regarding Cancer Subgroup DataValérie Côté, Institut national d'excellence en santé et services sociaux.(INESSS)Poster
Choosing Between Treatments for Anaplastic Lymphoma Kinase-Positive Non‒Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis Shannon Kelly, Cardiovascular Research Methods CentreJesse Elliott, CADTH
Dr. Zemin Bai, Cardiovascular Research Methods Centre
Dr. David Stewart, Division of Medical Oncology, University of Ottawa
Dr. George Wells, Cardiovascular Research Methods Centre
What Factors Drive Positive CADTH pan-Canadian Oncology Drug Review Recommendations for Notice of Compliance With Conditions Submissions? Orest Kobelak, University of Toronto, RocheSharu Kunasekaran, University of Toronto
Daniel Correia, University of Toronto
Lori Lin, Roche
Cost-Effectiveness Analysis of Rituximab Retreatment With Salvage Chemotherapy for Relapsed/Refractory Aggressive Histology CD20+ Lymphoma With Intent to Proceed to Autologous Stem Cell Transplant Jaclyn Beca, Ontario Health (Cancer Care Ontario)Shaun Walsh, Ontario Health (Cancer Care Ontario)
Elena Mow, Ontario Health (Cancer Care Ontario)
James Keech, Ontario Health (Cancer Care Ontario)
Dr. C Tom Kouroukis, McMaster University, and Juravinski Cancer Centre and Hospital
The Establishment of a Liaison Officer Within Health Technology Assessment During a HealthElisabeth Smitko, Ontario HealthNancy Sikich, Ontario Health
Sarah Garland, CADTH
How Certain Are We? Assessing the Limitations and Conclusions of Indirect Treatment ComparisonsMarina Richardson, CADTHBechara Farah, CADTH
Sheri Pohar, CADTH
The New Paradigm: Basket Studies in OncologyMarie-Eve Tremblay, Institut national d'excellence en santé et services sociaux.(INESSS)Poster
Inconsistencies in Opioid Prescribing at Transitions of Care Siyana Kurteva, McGill UniversityDr. Robyn Tamblyn, McGill UniversityPoster
Determining Cost-Effectiveness: Perspective MattersDr. Daria O'Reilly, TELUS HealthDr. Richard Lavoie, Synergyx ConsultingPoster
Applying the Minimally Important Difference of Health Utility Scores in the Calculation of Quality-Adjusted Life Years From Patient-Level DataNathan McClure, School of Public Health, University of AlbertaPoster
Impact of Zika Virus-Associated Neurological Disorders on Health-Related Quality of Life: A Systematic Review Rafael Miranda, Toronto Health Economics and Technology Assessment (THETA) CollaborativePoster
Patient Preferences Toward Characteristics to be Used in Prioritizing Patients for Bariatric Surgery: A Discrete Choice ExperimentDr. Jennifer Donnan, Memorial UniversityDr. Kristin Harris Walsh, Memorial University
Dr. Tanis Adey, Memorial University
Dr. Zhiwei Gao, Memorial University
Dr. Hai Nguyen, Memorial University
Jennifer Deon, Memorial University
Dr. Laurie Twells, Memorial University
Health Utilities Index Mark 3 Scores for Children: Population Norms for Canada Based on the 1994‒1995 National Longitudinal Survey of Children and Youth Brittany Humphries, Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster UniversityDr. Jason R. Guertin, Department of Social and Preventive Medicine, Faculty of Medicine, Université LavalPoster
Immediately Versus Delayed Sequential Bilateral Cataract Surgery in Children: A Cost-Effectiveness Analysis Alexandra Cernat, University of Toronto
Margaret Jamieson, University of Toronto
RuthAnne Kavelaars, University of Toronto
Dr. Sina Khalili, The Hospital for Sick Children (SickKids)Poster
Reporting of Probabilistic Uncertainty Alongside Estimates of Health Utilities in Childhood: A Systematic Review Yunfei Ma, University of TorontoJoseph Kwon, University of Sheffield
Prof. Stavros Petrou, University of Oxford
Dr. Wendy Ungar, The Hospital for Sick Children (SickKids)
Dr. Eleanor Pullenayegum, The Hospital for Sick Children (SickKids)
How Would a Single-Payer Publicly Funded National Pharmacare Program Affect the Quality of Access to Medicines for Canadian Patients? Viktoria Roman, Innovative Medicines CanadaSarah Lussier Hoskyn, Innovative Medicines CanadaPoster
Explaining Reimbursement Delays for New Medicines for Canadian Patients Sarah Lussier Hoskyn, Innovative Medicines CanadaPoster
Market Size of Patented Medicines in Canada: From Initial Uptake to the Decade after Launch Jihong Yang, Patented Medicine Prices Review Board
Elena Lungu, Patented Medicine Prices Review Board
Impact of Patented Medicine Prices Review Board New Reference Countries on Drug Prices in Canada: A Comparison of Current and Anticipated List Prices for Top Drugs in the CountryChloé Langevin, Université de MontréalPoster
Early Signs of Negative Impacts for Patients of Health Canada Pharmaceutical Pricing Reforms Sarah Lussier Hoskyn, Innovative Medicines Canada
Jason Field, Life Sciences Ontario
Cascade Genetic Testing and Health Service Use in Families of Children with Cardiomyopathy: Implications for Health Technology Assessment Alexandra Cernat, University of TorontoDr. Robin Hayeems, The Hospital for Sick Children (SickKids)Poster
A Real-World Observational Study of Somatostatin Analogue Use and Costs in Canada Dr. Winson Y Cheung, University of CalgaryDr. Marion Feuilly, Ipsen Pharma
Callahan Laforty, IQVIA
Anna Liovas, Ipsen Biopharmaceuticals Canada
Dr. Heather McKechnie, Ipsen Biopharmaceuticals Canada
Dr. Jonathan M. Loree, BC Cancer
Toward Standardized Structured Reporting for the Management of Multiple Myeloma in Alberta: Insights in Application of Machine LearningEileen Shaw, Medlior Health Outcomes ResearchPoster
Total Shoulder Arthroplasty is More Cost Effective than Hemiarthroplasty: A Real-world Economic EvaluationSrishti Kumar, Ottawa Hospital Research InstituteDr. Peter Lapner, Division of Orthopedic Surgery, The Ottawa Hospital
Dr. Kednapa Thavorn, Ottawa Hospital Research Institute
Frailty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review and Meta-analysis Zhe Li, Department of Epidemiology and Biostatistics, Western UniversityEmily Dawson, Western University
Jessica Moodie, London Health Sciences Centre
Dr. Janet Martin, Western University
Dr. Rodrigo Bagur, London Health Sciences Center
Dr. Ava John-Baptiste, Western University
Assistive Health Technology for Individuals With Dual Sensory Impairment: A Systematic Review Dr. Atul Jaiswal, University of MontrealErin Perfect, Queen's
Dr. Claire Davies, Queen's University University
Uncertainty and Global Value Assessment in Rare Diseases: Embedding Ethical Assessment in Knowledge Integration and Reflexive Multicriteria Approach Elise Courcault, Université de MontréalDr. Isabelle Ganache, INESSS
Dr. Mireille Goetghebeur, INESSS
Dr. Denis Roy, INESSS
When Less Means More: Insight Into Spending on Expensive Drugs for Rare DiseasesJared Berger, Patented Medicine Prices Review Board Elena Lungu, Patented Medicine Prices Review Board Poster
Canadian Blood Services: A National Formulary ManagerDr. Sarah Jennings, Canadian Blood Services
Dr. Utsav Patel, Canadian Blood Services
Dr. Sylvain Grenier, Canadian Blood Services
Teresa Petch, Canadian Blood Services
Rim Araia, Canadian Blood Services
Cost-Utility Analysis of the Electronic Patient Reported Outcomes (ePRO) Tool: An e-Health Solution for Community-Dwelling Complex Seniors in Ontario Aunima Bhuiya, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of TorontoRafael Miranda, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto
Zakariya Thraya, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto
Dr. Carolyn Steele Gray, Bridgepoint Collaboratory in Research and Innovation, Lunenfeld-Tanenbaum Research Institute
Dr. Walter Wodchis, Institute of Health Policy, Management and Evaluation, University of Toronto
Dr. Kednapa Thavorn, Ottawa Hospital Research Institute
How Patient Input is Used by CADTH: Insights From Feedback Letters Julie Boucher, CADTHSarah Berglas, CADTH
Tamara Rader, CADTH
Andrea Smith, CADTH
Patient Group Pathway Model to Accessing Cancer Clinical Trials (Pathway Model) & The Canadian Cancer Clinical Trials Stakeholder Charter (Charter)Barry Stein, Colorectal Cancer CanadaDr. Winson Y Cheung, Cancer Control Alberta
Dr. Michael Duong, Hoffmann-La Roche Limited
Dr. Stephanie Michaud, BioCanRx
Dr. Dawn Richards, Clinical Trials Ontario
Omalizumab Use in Severe Asthma in the Province of Alberta: A Quality Assurance Hailey Hitchings, University of AlbertaPoster
Biosimilar Transitioning — A Private Payer’s JourneyDr. Anar Dossa, Pacific Blue CrossPoster
Effectiveness and Patient Satisfaction with Treatment Options for Hidradenitis Suppurativa in Canada: Results from the Hidradenitis Suppurativa Patient Experience SurveyRachael Manion, Canadian Skin Patient AlliancePoster
Incorporating Patient Preferences Into a Quantitative Risk Benefit Analysis Comparing Sodium Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Type 2 DiabetesDr. Jennifer Donnan, Memorial UniversityPoster
Impact of COVID-19 on Access to Patient Care: National Patient SurveySheida Naderi-Azad, University of TorontoPoster
The Effectiveness of Community Face Mask Use for the Prevention of COVID-19 Transmission and InfectionLindsey Warkentin, Institute of Health EconomicsPoster
Caregivers’ Willingness to Accept Expedited Vaccine Research and Intent to Vaccinate Their Children During the COVID-19 PandemicRan Goldmand, University of British ColumbiaPoster
Canadian Council of the Blind’s COVID-19 Impact Study Reveals Disturbing Reality for Those Canadians Living With Vision LossDr. Keith Gordon, Canadian Council of the BlindPoster
Facilitating Urgent Evidence-Informed Decision-Making in Ontario During the COVID-19 PandemicSarah McDowell, Ontario Health, Health Technology AssessmentPoster
Digital Tools for Delivering Genetic Services During COVID-19 and Beyond: A Systematic ReviewDr. Robin Hayeems, The Hospital for Sick ChildrenPoster
Risk Factors for Severe Outcomes of COVID-19: A Rapid Review to Inform a Canadian Immunization StrategyJennifer Pillay, Alberta Research Centre for Health Evidence, University of AlbertaPoster
Vaccine Hesitancy and Acceptance During Pandemics and Global OutbreaksJudy Truong, Acorn BiolabsPoster
Utilization of Hydroxychloroquine and Azithromycin in Canada During the COVID-19 Pandemic: Experience From a Large Canadian Private PayerNianda Penner, Sun LifePoster
Health Care Resource Utilization and Direct Health Care Costs in Ontario Patients With COVID-19Teresa Tsui, Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health NetworkPoster
Monitoring, Access and Clinical Use of Potential Drugs During the COVID-19 Pandemic: The Case of Remdesivir in the Quebec ContextStéphane Gilbert, Institut national d'excellence en santé et en services sociaux (INESSS)Poster
Fostering a Responsible Conduct for the Development, Evaluation and Access to Promising Interventions During the COVID-19 PandemicOlivier Catherine, Institut national d'excellence en santé et services sociaux (INESSS)Poster
Managing Influenza During the COVID-19 Pandemic: Detection and Treatment Decision-making Tools for Quebec’s Health ProfessionalsJulie Lefebvre, Institut national d'excellence en santé et en services sociaux (INESSS)Poster
Predicting Waitlist Volumes and Health Outcomes of Abdominal Aortic Aneurysm Repairs During COVID-19 in Ontario Using a Microsimulation ModelMarina Richardson, University of Toronto and The Toronto Health Economics and Technology Assessment (THETA) CollaborativePoster
Assessing The Risk Of Hospitalization For Severe Acute Respiratory Syndrome Coronavirus 2 Infected Persons In QuebecFrederique Baril, Institut national d'excellence en santé et en services sociaux (INESSS)Poster
An Approach to Understanding and Modelling Demand for Essential Medications in a Pandemic: Lessons and Projections for COVID-19 Approach to Understanding and Modelling Demand for Essential Medications in a Pandemic: Lessons and Projections for COVID-19Ryan O'Reilly, McMaster UniversityPoster
Programme de Suivi à Distance Des Patients COVID-19 En Post HospitalisationKhayreddine Bouabida, Université de MontréalPoster
Evidence-Based Criteria and Indications Supporting Relevant Use of COVID-19 Test CapacitiesCatherine Gravel, Institut national d'excellence en santé et en services sociaux (INESSS)Poster
Development of the COVID-19 Decision Model to Optimize Quality and Access to Patient Care While Considering the Best Value for Money and Use of Available Hospital ResourcesAleksandra Stanimirovic, Toronto General Research Institute, University Health NetworkPoster